NLRP3 and Alzheimer disease: Moreover, a growing body of evidence suggests that caspase-1 activation and pro-inflammatory cytokine (such as IL-1β) production occur before AD pathology, showing that activation of the microglial NLRP3 inflammasome represents an early pathogenic event in AD [47].